Reveal is transforming medical insight, improving human health, and positively impacting the environment.
Over 40M contrast-enhanced magnetic resonance imaging (MRI) scans are performed each year. Current MRI contrast agents all cause accumulation of the heavy metal gadolinium in the brain and body of every patient, and drive rising levels of gadolinium in surface waters. Reveal’s patented contrast agents are based on manganese, which is essential for life. Reveal’s gadolinium-free MRI contrast agent, RVP-001, currently in Phase 2 clinical studies, promises to directly replace current MRI contrast agents, benefiting patients and the planet.
Company Details
- Employees
- 9
- Founded
- -
- Address
- ., Cambridge,ma 02140,united States
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- revealpharma.com
- HQ
- Cambridge, MA
Reveal Pharmaceuticals Questions
Reveal Pharmaceuticals's website is revealpharma.com
Reveal Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/revealpharma
Reveal Pharmaceuticals has
9 employees.
View email and phone details for 9
employees at Reveal Pharmaceuticals.
Reveal Pharmaceuticals's industry is
Biotechnology Research
Reveal Pharmaceuticals's top competitors are
Acrivon Therapeutics, Inc.,
Alkeus Pharmaceuticals, Inc.,
Brainkey,
Sheffield Pharmaceuticals, Llc,
Sebela Pharmaceuticals Inc.,
Morphoceuticals,
Sarepta Therapeutics,
Revel Pharmaceuticals,
Lysoway Therapeutics,
Spectrum Pharmaceuticals, Inc..
Reveal Pharmaceuticals's support email address is info@revealpharma.com
Reveal Pharmaceuticals's categories are Biotechnology Research
Reveal Pharmaceuticals's founding year is 2016
